258 related articles for article (PubMed ID: 4143199)
1. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Preece AW; Light PA
Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
[TBL] [Abstract][Full Text] [Related]
2. Studies with the macrophage migration inhibition (MMI) test in patients with malignant disease.
Light PA; Preece AW; Waldron HA
Clin Exp Immunol; 1975 Nov; 22(2):279-84. PubMed ID: 55328
[TBL] [Abstract][Full Text] [Related]
3. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
[TBL] [Abstract][Full Text] [Related]
4. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
5. The macrophage electrophoretic mobility test for malignancy.
Lubran MM
Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
[No Abstract] [Full Text] [Related]
6. The macrophage electrophoretic migration test in cancer.
Goldstone AH; Kerr L; Irvine WJ
Clin Exp Immunol; 1973 Jul; 14(3):469-72. PubMed ID: 4125154
[TBL] [Abstract][Full Text] [Related]
7. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
Balakrishnan K; Hanjan SN; Talwar JP
Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
[No Abstract] [Full Text] [Related]
8. [In vitro reaction of lymph node cells of mice to protein and cell-bound antigens. A study with the macrophage electrophoretic mobility test ].
Schäffner H
Allerg Immunol (Leipz); 1981; 27(3):145-52. PubMed ID: 6181671
[TBL] [Abstract][Full Text] [Related]
9. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
Jenssen R; Jenssen HL; Köhler H; Friemel H
Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
[TBL] [Abstract][Full Text] [Related]
10. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
11. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
Nakajima T; Isojima K; Iwaguchi T
Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
[No Abstract] [Full Text] [Related]
12. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
Shenton BK; Hughes D; Field EJ
Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
[TBL] [Abstract][Full Text] [Related]
13. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics of production of macrophage migration inhibitory factors in mixed culture of lymphocytes and tumor cells].
Kharkevich DD; Suslov AP
Biull Eksp Biol Med; 1982 Feb; 93(2):53-5. PubMed ID: 6461371
[No Abstract] [Full Text] [Related]
15. Macrophage electrophoretic mobility test for brain tumors and malignancies.
Yongde S; Zhensheng T; Chuanshen L; Baoguo X; Zijun L; Yifei S; Yanfang J; Xindi Y; Meizhen L; Xuezhen S
Chin Med J (Engl); 1979 Mar; 92(3):211-5. PubMed ID: 109261
[No Abstract] [Full Text] [Related]
16. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
[TBL] [Abstract][Full Text] [Related]
17. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
18. [Experiences with the macrophage electrophoresis mobility test (MEM test) in the diagnosis of malignant gynecological diseases].
Günther J
Zentralbl Bakteriol Orig B; 1975; 91(9):529-39. PubMed ID: 52961
[TBL] [Abstract][Full Text] [Related]
19. The macrophage electrophoretic mobility (MEM) test--an investigation of its value as a routine laboratory test in the detection of malignant disease.
Pritchard JA; Sutherland WH; Teasdale C; Whitehead RH; Deeley TJ; Hughes LE
Ann Clin Res; 1978 Apr; 10(2):71-4. PubMed ID: 354473
[TBL] [Abstract][Full Text] [Related]
20. [Migration inhibitory test and its clinical aspects].
Dobozy A; Hunyadi J; Simon N
Berufsdermatosen; 1973 Aug; 21(4):137-51. PubMed ID: 4583667
[No Abstract] [Full Text] [Related]
[Next] [New Search]
